121
Views
37
CrossRef citations to date
0
Altmetric
Review

Update on the risk of lymphoma following immunosuppressive therapy for inflammatory bowel disease

&
Pages 621-631 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Anthony Mark Dalzell & Muhammad Eyad Ba’Ath. (2019) Paediatric inflammatory bowel disease: review with a focus on practice in low- to middle-income countries. Paediatrics and International Child Health 39:1, pages 48-58.
Read now
Neeraj Kumar, Heerak Chugh, Ravi Tomar, Vartika Tomar, Vimal Kishor Singh & Ramesh Chandra. (2018) Exploring the interplay between autoimmunity and cancer to find the target therapeutic hotspots. Artificial Cells, Nanomedicine, and Biotechnology 46:4, pages 658-668.
Read now
Pauliina Molander, Martti Färkkilä, Helena Kemppainen, Timo Blomster, Airi Jussila, Harri Mustonen & Taina Sipponen. (2017) Long-term outcome of inflammatory bowel disease patients with deep remission after discontinuation of TNFα-blocking agents. Scandinavian Journal of Gastroenterology 52:3, pages 284-290.
Read now
Stephen B Hanauer & Daan W Hommes. (2010) Inflammatory bowel disease. Expert Review of Clinical Immunology 6:4, pages 499-500.
Read now

Articles from other publishers (33)

Chang-Yu Hsieh & Tsen-Fang Tsai. (2023) Rapid progression of cutaneous T-cell lymphoma in a patient with erythroderma during dupilumab treatment, following prior sequential azathioprine, baricitinib and cyclosporine treatments. Indian Journal of Dermatology, Venereology and Leprology 0, pages 1-3.
Crossref
Jingru Yu, Erle Refsum, Paulina Wieszczy, Lise M Helsingen, Vera Perrin, Amanda Högdén, Magnus Løberg, Johannes Blom, Michael Bretthauer, Hans-Olov Adami, Weimin Ye & Mette Kalager. (2023) Risk of malignant lymphomas in patients with inflammatory bowel disease: a population-based cohort study. BMJ Open Gastroenterology 10:1, pages e001037.
Crossref
Kosha Kantharia, Carolyn Owen, Douglas Stewart, Patrick Yau, Sunita Ghosh & Deonne Dersch-Mills. (2022) Characteristics and Outcomes of Alberta Lymphoma Patients with a History of Immunosuppressive therapy for Autoimmune Conditions. Clinical Lymphoma Myeloma and Leukemia 22:12, pages 894-902.
Crossref
Yu‐Ju Chou, Chun‐Ying Wu, Tzu‐Yun Pan, Chen‐Yi Wu & Yun‐Ting Chang. (2022) Risk of malignancy in patients with psoriasis receiving systemic medications: A nested case‐control study. Dermatologic Therapy 35:11.
Crossref
Gregory S. Day. (2022) Rapidly Progressive Dementia. CONTINUUM: Lifelong Learning in Neurology 28:3, pages 901-936.
Crossref
Phuong Vo, Lynn Onstad, Mary E. Flowers & Rainer Storb. (2021) Cancers after HLA-matched related bone marrow transplantation for aplastic anemia. Bone Marrow Transplantation 57:1, pages 83-88.
Crossref
Magda Zanelli, Francesca Sanguedolce, Andrea Palicelli, Maurizio Zizzo, Giovanni Martino, Cecilia Caprera, Valentina Fragliasso, Alessandra Soriano, Luca Valle, Stefano Ricci, Fabrizio Gozzi, Luca Cimino, Alberto Cavazza, Francesco Merli, Stefano A. Pileri & Stefano Ascani. (2021) EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 2). Cancers 13:18, pages 4527.
Crossref
Vipul Yadav, Yang Mai, Laura E. McCoubrey, Yasufumi Wada, Motoyasu Tomioka, Satofumi Kawata, Shrikant Charde & Abdul W. Basit. (2021) 5-Aminolevulinic Acid as a Novel Therapeutic for Inflammatory Bowel Disease. Biomedicines 9:5, pages 578.
Crossref
David Bergman, Hamed Khalili, Bjorn Roelstraete & Jonas F Ludvigsson. (2021) Microscopic Colitis and Risk Of Cancer—AA Population-Based Cohort Study. Journal of Crohn's and Colitis 15:2, pages 212-221.
Crossref
Ana Maria Alexandra Stănescu, Anca A. Simionescu, Marina Ruxandra Oţelea & Ioana Veronica Grăjdeanu. (2021) The risk of malignancy in therapies used in patients with psoriasis. Oncolog-Hematolog.ro 4:57, pages 41.
Crossref
Hsien‐Chung Yu. (2020) Primary colonic lymphoma in patients with inflammatory bowel disease: Is it treatment‐ or disease‐related adverse event?. Advances in Digestive Medicine 7:4, pages 177-178.
Crossref
Cheng‐Lu Lin, Cheng‐Kuan Lin, Yew‐Loong Leong, Chien‐Chih Tung, Chia‐Tung Shun, Shu‐Chen Wei, Jau‐Min Wong & Meng‐Tzu Weng. (2020) Ulcerative colitis associated with primary colorectal lymphoma in Taiwan: A tertiary center study. Advances in Digestive Medicine 7:4, pages 195-200.
Crossref
Francesca Sanguedolce, Magda Zanelli, Maurizio Zizzo, Giovanni Martino, Cristiana Rossi, Paola Parente & Stefano Ascani. (2020) Clinical, pathological and molecular features of plasmablastic lymphoma arising in the gastrointestinal tract: A review and reappraisal. Pathology - Research and Practice 216:6, pages 152973.
Crossref
James Dotimas, Manjusha Das & Daniel Martin. (2020) Cutaneous T-cell lymphoma in the setting of anti-tumor necrosis factor and immunomodulator therapy: A case report and literature review. SAGE Open Medical Case Reports 8, pages 2050313X2093722.
Crossref
Chip Alex Bowman & Garrett Lawlor. 2019. Cancer Screening in Inflammatory Bowel Disease. Cancer Screening in Inflammatory Bowel Disease 61 73 .
Mona Panahi, Nimai Vadgama, Mathun Kuganesan, Fu Ng & Susanne Sattler. (2018) Immunopharmacology of Post-Myocardial Infarction and Heart Failure Medications. Journal of Clinical Medicine 7:11, pages 403.
Crossref
Mona Panahi, Angelos Papanikolaou, Azam Torabi, Ji-Gang Zhang, Habib Khan, Ali Vazir, Muneer G Hasham, John G F Cleland, Nadia A Rosenthal, Sian E Harding & Susanne Sattler. (2018) Immunomodulatory interventions in myocardial infarction and heart failure: a systematic review of clinical trials and meta-analysis of IL-1 inhibition. Cardiovascular Research 114:11, pages 1445-1461.
Crossref
Shamir Geller, Haoming Xu, Mark Lebwohl, Beatrice Nardone, Mario E. Lacouture & Meenal Kheterpal. (2017) Malignancy Risk and Recurrence with Psoriasis and its Treatments: A Concise Update. American Journal of Clinical Dermatology 19:3, pages 363-375.
Crossref
David T. Beattie, M. Teresa Pulido-Rios, Fei Shen, Melissa Ho, Eva Situ, Pam R. Tsuruda, Patrick Brassil, Melanie Kleinschek & Sharath Hegde. (2017) Intestinally-restricted Janus Kinase inhibition: a potential approach to maximize the therapeutic index in inflammatory bowel disease therapy. Journal of Inflammation 14:1.
Crossref
Jeffrey S. Hyams, Marla C. Dubinsky, Robert N. Baldassano, Richard B. Colletti, Salvatore Cucchiara, Johanna Escher, William Faubion, John Fell, Benjamin D. Gold, Anne Griffiths, Sibylle Koletzko, Subra Kugathasan, James Markowitz, Frank M. Ruemmele, Gigi Veereman, Harland Winter, Nicholas Masel, Chu Ri Shin, Kezhen L. Tang & Meena Thayu. (2017) Infliximab Is Not Associated With Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric Patients With Inflammatory Bowel Disease. Gastroenterology 152:8, pages 1901-1914.e3.
Crossref
Suthida Intaraphet, Dóra Körmendiné Farkas, Sigrun Alba Johannesdottir Schmidt, Deirdre Cronin-Fenton & Mette Søgaard. (2017) Human papillomavirus infection and lymphoma incidence using cervical conization as a surrogate marker: a Danish nationwide cohort study. Hematological Oncology 35:2, pages 172-176.
Crossref
Regan Stephenson & Ankur Singh. (2017) Drug discovery and therapeutic delivery for the treatment of B and T cell tumors. Advanced Drug Delivery Reviews 114, pages 285-300.
Crossref
Aakash Aggarwal, Timothy Sabol & Haleh Vaziri. (2017) Update on the Use of Biologic Therapy in Ulcerative Colitis. Current Treatment Options in Gastroenterology 15:1, pages 155-167.
Crossref
Jee Hyun KimJi Won Kim. (2017) Effect of Immunomodulators and Biologic Agents on Malignancy in Patients with Inflammatory Bowel Disease. Korean Journal of Gastroenterology 70:4, pages 162.
Crossref
Joerg-Patrick Stübgen. (2016) Inflammatory myopathies and lymphoma. Journal of the Neurological Sciences 369, pages 377-389.
Crossref
Amol Agarwal, Frank I. Scott, Nuzhat A. Ahmad & Vinay Chandrasekhara. (2016) Chronic immunosuppression does not potentiate the malignant progression of mucinous pancreatic cystic lesions. Pancreatology 16:5, pages 900-904.
Crossref
Yoko Yokoyama, Kenji Watanabe, Hiroaki Ito, Masakazu Nishishita, Koji Sawada, Yusuke Okuyama, Kazuichi Okazaki, Hisao Fujii, Hiroshi Nakase, Tsutomu Masuda, Ken Fukunaga, Akira Andoh & Shiro Nakamura. (2015) Factors associated with treatment outcome, and long-term prognosis of patients with ulcerative colitis undergoing selective depletion of myeloid lineage leucocytes: a prospective multicenter study. Cytotherapy 17:5, pages 680-688.
Crossref
Pauliina Molander, Martti Färkkilä, Kimmo Salminen, Helena Kemppainen, Timo Blomster, Ritva Koskela, Airi Jussila, Henna Rautiainen, Markku Nissinen, Johanna Haapamäki, Perttu Arkkila, Urpo Nieminen, Juha Kuisma, Jari Punkkinen, Kaija-Leena Kolho, Harri Mustonen & Taina Sipponen. (2014) Outcome After Discontinuation of TNFα-blocking Therapy in Patients with Inflammatory Bowel Disease in Deep Remission. Inflammatory Bowel Diseases, pages 1.
Crossref
Jason G. DominaJonathan R. DillmanJeremy AdlerEmmanuel ChristodoulouShokoufeh KhalatbariAdam L. DorfmanPeter J. Strouse. (2013) Imaging Trends and Radiation Exposure in Pediatric Inflammatory Bowel Disease at an Academic Children's Hospital. American Journal of Roentgenology 201:1, pages W133-W140.
Crossref
Natasha M. Savage, Ryan C. Johnson & Yasodha Natkunam. (2013) The spectrum of lymphoblastic, nodal and extranodal T-cell lymphomas: characteristic features and diagnostic dilemmas. Human Pathology 44:4, pages 451-471.
Crossref
A. Sandhu, T. Alameel, C. H. Dale, M. Levstik & N. Chande. (2012) The safety and efficacy of antitumour necrosis factor‐alpha therapy for inflammatory bowel disease in patients post liver transplantation: a case series. Alimentary Pharmacology & Therapeutics 36:2, pages 159-165.
Crossref
Lori A. Ashworth, Amy Billett, Paul Mitchell, Federica Nuti, Corey Siegel & Athos Bousvaros. (2012) Lymphoma risk in children and young adults with inflammatory bowel disease: Analysis of a large single-center cohort. Inflammatory Bowel Diseases 18:5, pages 838-843.
Crossref
Rocio Plaza, Angel Ponferrada, Dulce M. Benito, Noelia Arevalo, Maria Angeles Foncillas, Maria Luisa de Fuenmayor & Mercedes Aldeguer. (2011) Plasmablastic lymphoma associated to Crohn's disease and hepatitis C virus chronic infection. Journal of Crohn's and Colitis 5:6, pages 628-632.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.